Found: 8
Select item for more details and to access through your institution.
Molecular interactions of dioxins and DLCs with the xenosensors (PXR and CAR): An in silico risk assessment approach.
- Published in:
- Journal of Molecular Recognition, 2017, v. 30, n. 12, p. n/a, doi. 10.1002/jmr.2651
- By:
- Publication type:
- Article
A review exploring biological activities of hydrazones.
- Published in:
- Journal of Pharmacy & Bioallied Sciences, 2014, v. 6, n. 2, p. 69, doi. 10.4103/0975-7406.129170
- By:
- Publication type:
- Article
Anticancer heterocyclic hybrids: design, synthesis, molecular docking and evaluation of new thiazolidinone-pyrazoles.
- Published in:
- Zeitschrift für Naturforschung B: A Journal of Chemical Sciences, 2023, v. 78, n. 1/2, p. 1, doi. 10.1515/znb-2022-0110
- By:
- Publication type:
- Article
Synthesis, and reverse screening of 6‐(3,4,5‐trimethoxyphenyl)pyrimidine‐5‐carbonitrile derivatives as anticancer agents: Part‐II.
- Published in:
- Journal of Heterocyclic Chemistry, 2022, v. 59, n. 4, p. 771, doi. 10.1002/jhet.4421
- By:
- Publication type:
- Article
Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targets.
- Published in:
- Journal of Heterocyclic Chemistry, 2022, v. 59, n. 1, p. 22, doi. 10.1002/jhet.4355
- By:
- Publication type:
- Article
Synthesis and biological evaluation of benzimidazole pendant cyanopyrimidine derivatives as anticancer agents.
- Published in:
- Journal of Heterocyclic Chemistry, 2020, v. 57, n. 9, p. 3350, doi. 10.1002/jhet.4052
- By:
- Publication type:
- Article
Design and synthesis of pyrazole–pyrazoline hybrids as cancer‐associated selective COX‐2 inhibitors.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 1, p. 1, doi. 10.1002/ardp.202000116
- By:
- Publication type:
- Article
Dodging blood brain barrier with "nano" warriors: Novel strategy against ischemic stroke.
- Published in:
- Theranostics, 2022, v. 12, n. 2, p. 689, doi. 10.7150/thno.64806
- By:
- Publication type:
- Article